Adam Cotton
PhD, MBA

About

Adam Cotton PhD, MBA is an associate at the Novartis Venture Fund in Cambridge, MA, USA. Prior to joining NVF, he worked in the labs of Jim Wells and Ian Seiple on antibody engineering research. He is a scientific co-founder of Epi Biologics. He helped build both Rezo Therapeutics and HYKU Biosciences as they transitioned from their respective academic labs. He holds a BA in Chemistry from Harvard University, an MBA from the University of New Mexico, and a PhD in Chemistry & Chemical Biology from the University of California, San Francisco.

Investments

• Mediar Therapeutics (Observer)
• HYKU Biosciences (Observer)
• GentiBio (Observer) 
• Arvada Therapeutics (Observer)